Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation

Abstract

Circulating tumor cells (CTCs) are cells that detach from the primary tumor and enter the bloodstream, playing a crucial role in the metastasis of lung cancer. Unfortunately, there is currently a lack of drugs specifically designed to target CTCs and prevent tumor metastasis. In this study, we present evidence that polyphyllin VII, a potent anticancer compound, effectively inhibits the metastasis of lung cancer by inducing a process called anoikis in CTCs. We observed that polyphyllin VII had significant cytotoxicity and inhibited colony formation, migration, and invasion in both our newly established cell line CTC-TJH-01 and a commercial lung cancer cell line H1975. Furthermore, we found that polyphyllin VII induced anoikis and downregulated the TrkB and EGFR-MEK/ERK signaling pathways. Moreover, activation of TrkB protein did not reverse the inhibitory effect of polyphyllin VII on CTCs, while upregulation of EGFR protein effectively reversed it. Furthermore, our immunodeficient mouse models recapitulated that polyphyllin VII inhibited lung metastasis, which was associated with downregulation of the EGFR protein, and reduced the number of CTCs disseminated into the lungs by inducing anoikis. Together, these results suggest that polyphyllin VII may be a promising compound for the treatment of lung cancer metastasis by targeting CTCs.

Polyhydroxylated Spirostanol Saponins from the Rhizomes of Paris dulongensis

“…[1][2][3] More than ten Paris plants are used as traditional medicines. [4] Previous studies have shown that steroidal saponins are the main active ingredients of Paris species and have antitumor, [5][6][7][8][9][10] hemostatic, [11] antiinflammatory, [12] antimicrobial, [13] and antiangiogenic effects [14] and other biological activities.…”